These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 9222067)
1. Antibacterial activity of trovafloxacin against nosocomial Gram-positive and Gram-negative isolates. Cunha BA; Qadri SM; Ueno Y; Walters EA; Domenico P J Antimicrob Chemother; 1997 Jun; 39 Suppl B():29-34. PubMed ID: 9222067 [TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer. Rolston KV; Ho DH; LeBlanc B; Streeter H; Dvorak T J Antimicrob Chemother; 1997 Jun; 39 Suppl B():15-22. PubMed ID: 9222065 [TBL] [Abstract][Full Text] [Related]
3. Comparative in-vitro activities of trovafloxacin, ciproflaxacin, ofloxacin, and broad-spectrum beta-lactams against aerobe blood culture isolates. Seifert H Zentralbl Bakteriol; 1998 Dec; 288(4):509-18. PubMed ID: 9987189 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity of trovafloxacin (CP 99,219), a new fluoroquinolone against hospital isolates. Ling TK; Liu EY; Cheng AF Chemotherapy; 1999; 45(1):22-7. PubMed ID: 9876206 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials. Qadri SM; Lee GC; Ellis ME Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304 [TBL] [Abstract][Full Text] [Related]
6. Comparative activity of the new fluoroquinolone rufloxacin (MF 934) against clinical isolates of gram-negative and gram-positive bacteria. Qadri SM; Ueno Y; Postle G; Tullo D; San Pedro J Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):372-7. PubMed ID: 8394816 [TBL] [Abstract][Full Text] [Related]
7. The in-vitro activity of trovafloxacin, a new fluoroquinolone, against Gram-positive bacteria. Sefton AM; Maskell JP; Rafay AM; Whiley A; Williams JD J Antimicrob Chemother; 1997 Jun; 39 Suppl B():57-62. PubMed ID: 9222071 [TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones. Montanari MP; Prenna M; Mingoia M; Ripa S; Varaldo PE Chemotherapy; 1998; 44(2):85-93. PubMed ID: 9551237 [TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates. Arpi M; Gahrn-Hansen B; Søgaard P; Bentzon MW Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910 [TBL] [Abstract][Full Text] [Related]
12. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections. Hoogkamp-Korstanje JA J Antimicrob Chemother; 1997 Sep; 40(3):427-31. PubMed ID: 9338498 [TBL] [Abstract][Full Text] [Related]
13. The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones. Wise R; Brenwald NP; Andrews JM; Boswell F J Antimicrob Chemother; 1997 Apr; 39(4):447-52. PubMed ID: 9145816 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone. Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N Chemotherapy; 1992; 38(2):99-106. PubMed ID: 1317282 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of trovafloxacin versus ciprofloxacin against clinical isolates. Verbist L; Verhaegen J Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):683-5. PubMed ID: 8894581 [TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study. Hoban DJ; Bouchillon SK; Johnson JL; Zhanel GG; Butler DL; Miller LA; Poupard JA; Diagn Microbiol Infect Dis; 2001; 40(1-2):51-7. PubMed ID: 11448564 [TBL] [Abstract][Full Text] [Related]
17. Comparison of in vitro activity of trovafloxacin against gram-positive and gram-negative organisms with quinolones and beta-lactam antimicrobial agents. Dembry LM; Roberts JC; Schock KD; Marino SP; Farrel PA; Andriole VT Diagn Microbiol Infect Dis; 1998 May; 31(1):301-11. PubMed ID: 9597391 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of trovafloxacin against ciprofloxacin-susceptible and -resistant clinical bacterial isolates and assessment of the trovafloxacin disk test. Fuchs PC; Barry AL; Brown SD Diagn Microbiol Infect Dis; 1999 Jan; 33(1):33-8. PubMed ID: 9990473 [TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro potency of gemifloxacin and fluoroquinolones against recent European clinical isolates from a global surveillance study. Hoban DJ; Bouchillon SK; Johnson JL; Zhanel GG; Butler DL; Miller LA; Poupard JA; Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):814-9. PubMed ID: 11783700 [TBL] [Abstract][Full Text] [Related]
20. [In vitro activity of trovafloxacin (CP-99,219) against 434 bacterial strains: comparative study with other fluoroquinolones]. Tali-Maamar H; Tebbal S; Rahal K Arch Inst Pasteur Alger; 1998; 62():52-61. PubMed ID: 11256319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]